Heart allograft tolerance without development of posttransplant cardiac allograft vasculopathy in chimerism-based, drug-induced tolerance

Transplantation

Volumn 73, Issue 4, 2002, Pages 652-656

  Zhang, Qi Wei ^a   Tomita, Yukihiro ^a   Matsuzaki, Goro ^a   Shimizu, Ichiro ^a   Iwai, Toshiro ^a   Okano, Shinji ^a   Minagawa, Ryosuke ^a   Nakashima, Yutaka ^a   Sueishi, Katsuo ^a   Nomoto, Kikuo ^a   Yasui, Hisataka ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; FLOW CYTOMETRY; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOPATHOLOGY; HLA MATCHING; IMMUNOLOGICAL TOLERANCE; MOUSE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; TREATMENT OUTCOME; VASCULAR DISEASE;

EID: 0037181092     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200202270-00031     Document Type: Article

References (27)

1. Drug-induced tolerance to allografts in mice. I. Difference between tumor and skin grafts
2. Drug-induced tolerance to allografts in mice. IV. Tolerance induction in H-2-haplotype-identical strain combinations in mice
3. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance?
4. + T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mlsdisparate antigens
5. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion
6. Fractionated dosing of cyclophosphamide for establishing long-lasting skin allograft survival, stable mixed chimerism, and intrathymic clonal deletion in mice primed with allogeneic spleen cells
7. Induction of permanent mixed chimerism and skin allograft tolerance across fully MHC mismatched barriers by the additional myelosuppressive treatment in mice primed with allogeneic spleen cells followed by cyclophosphamide
8. Improved technique of heterotopic cervical heart transplantation in mice
9. Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis
10. Transplantation immunology
11. Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis
12. Cardiac transplantation in the rat. II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response
13. Cytokines. Structure, function, and role in immune response amplification
14. Cardiac allograft vasculopathy is abrogated by anti-CD8 monoclonal antibody therapy
15. Chronic allograft rejection
16. Prevention of chronic rejection and graft arteriosclerosis by tolerance induction
17. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts
18. Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide
19. Mixed hematopoietic chimerism and transplantation tolerance
20. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen
21. Mechanism for cotolerance in nonlethally conditioned mixed chimeras: Negative selection of the Vbeta T-cell receptor repertoire by both host and donor bone marrow-derived cells
22. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys
23. Tolerization of anti-Gal(α1-3)Gal natural antibody-forming B cells by induction of mixed chimerism
24. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts
25. Mixed chimerism and permanent specific transplantation tolerance induced by a nonlethal preparative regimen
26. Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment